1. Home
  2. AFBI vs SPRO Comparison

AFBI vs SPRO Comparison

Compare AFBI & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AFBI

Affinity Bancshares Inc. (MD)

N/A

Current Price

$22.55

Market Cap

137.0M

Sector

Finance

ML Signal

N/A

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.22

Market Cap

156.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AFBI
SPRO
Founded
1928
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
137.0M
156.3M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
AFBI
SPRO
Price
$22.55
$2.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.5K
1.6M
Earning Date
04-24-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
55.42
111.81
EPS
0.36
N/A
Revenue
N/A
$66,802,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$300.00
P/E Ratio
$62.64
N/A
Revenue Growth
N/A
39.24
52 Week Low
$18.32
$1.80
52 Week High
$22.59
$3.08

Technical Indicators

Market Signals
Indicator
AFBI
SPRO
Relative Strength Index (RSI) 66.96 42.65
Support Level $22.45 $2.14
Resistance Level N/A $2.52
Average True Range (ATR) 0.03 0.26
MACD -0.01 -0.06
Stochastic Oscillator 92.86 28.64

Price Performance

Historical Comparison
AFBI
SPRO

About AFBI Affinity Bancshares Inc. (MD)

Affinity Bancshares Inc is a bank holding company. The bank provides a range of financial services, including checking and savings accounts, certificates of deposit, mortgage, commercial and consumer loans, and money transfer services, operating across parts of Georgia and offering specialized lending such as dental practice and indirect automobile loans across the Southeastern United States. Its business mainly involves accepting public deposits and investing them in real estate and commercial loans, as well as mortgage-backed securities. The company also gathers deposits nationwide through its virtual bank, FitnessBank, and uses additional funding sources such as Federal Home Loan Bank borrowings.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: